|
CRA Handbook 2011 Electronic Edition
The electronic version of the CRA Handbook is formatted in 10-point Verdana type for easy on-screen viewing. Provided as an Acrobat pdf document, it is designed specifically for loading onto your laptop or other hard-drive. The handbook is indexed for faster searching and is bookmarked for ready location of information. It is fully annotate-able if you have Acrobat Writer—a big plus if you like to make field notes. It is not printable. Contents[Ch 1] 21 CFR Part 812—Investigational Device Exemption Regulations [Ch 2] 21 CFR Part 814.20 Subpart B—PMA Approval of Medical Devices [Ch 3] 21 CRF Part 11—Electronic Records; Electronic Signatures [Ch 4] 21 CFR Part 50—Protection of Human Subjects [Ch 5] 21 CFR Part 54—Financial Disclosure by Clinical Investigators [Ch 6] 21 CFR Part 56—Institutional Review Boards [Ch 7] 21 CFR Part 99—Dissemination of Information on Unapproved/New Uses…. [Ch 8] 21 CFR Part 809—In Vitro Diagnostic Products [Ch 9] 21 CFR Part 820.30—Quality System Regulation [Ch 10] Expedited Review List [Ch 11] FDA Guidelines for the Monitoring of Clinical Investigations [Ch 12] Overview of the Monitoring Process [Ch 13] Declaration of Helsinki (2008) [Ch 14] ISO 14155 “Clinical Investigation of Medical Devices in human subjects—good clinical practices” (2011) (excerpts) [Ch 15] Adverse Events & Effects [Ch 16] FDA Guidances [Figure 1] US Studies under the Investigational Device Exemptions |